• Kadimastem Receives Approval for ALS Patient Clinical Trial americanpharmaceuticalreview
    June 22, 2017
    Kadimastem announced it had received approval from the IRB of the Hadassah Ein Kerem Hospital for the phase 1/2a clinical trial in ALS patients using the cell therapy product developed by the company.
PharmaSources Customer Service